Short report: In vitro activity of artemisone compared with artesunate against Plasmodium falciparum

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue 4, 2006, Pages 637-639

  Ramharter, Michael ^a,b   Burkhardt, Dominik ^b,c   Nemeth, Johannes ^a,b   Adegnika, Ayola A ^b,c   Kremsner, Peter G ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ALBERT SCHWEITZER HOSPITAL   (Gabon)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ DERIVATIVE; ARTEMISONE; ARTESUNATE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; SESQUITERPENE;

ARTICLE; DRUG ACTIVITY; IN VITRO STUDY; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG SENSITIVITY; HUMAN; REGRESSION ANALYSIS;

ARTESUNATE; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; HUMANS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; REGRESSION ANALYSIS; SESQUITERPENES;

EID: 33750611822     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.637     Document Type: Article

References (19)

1. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group., 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363: 9-11.
2. Kremsner PG, Krishna S, 2004. Antimalarial combinations. Lan cet 364: 285-294.
3. Ashley EA, White NJ, 2005. Artemisinin-based combinations. Curr Opin Infect Dis 18: 531-536.
4. Leonardi E, Gilvary G, White NJ, Nosten F, 2001. Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg 95: 182-183.
5. Genovese RF, Nguyen HA, Mog SR, 2001. Effects of arteether on an auditory radial-arm maze task in rats. Physiol Behav 73: 87-91.
6. Genovese RF, Newman DB, Brewer TG, 2000. Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artetinate, in rats. Pharmacol Biochem Behav 67: 31-44.
7. . Panossian LA, Garga NI, Pelletier D, 2005. Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol 58: 812-813.
8. Toovey S, Jamieson A, 2004. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98: 261-267.
9. Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, Chan HW, Cheung MK, Lam WL, Wong HN, Croft SL, Vivas L, Rattray L, Steward L, Peters W, Robinson BL, Edstein MD, Kotecka B, Kyle DE, Beckermann B, Gerisch M, Radtke M, Schmuck G, Steinke W, Wollborn U, Schmeer K, Romer A, 2006. Artemisone: a highly active antimalarial drug of the artemisinin class. Angew Chem Int Ed Engl 45: 2082-2088.
10. Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ramharter M, Wernsdorfer WH, Kremsner PG, 2002. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg 96: 660-663.
11. Ramharter M, Wernsdorfer WH, Kremsner PG, 2004. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop 90: 55-60.
12. Uhlemann AC, Ramharter M, Lell B, Kremsner PG, Krishna S, 2005. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis 192:1830-1835.
13. Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C, 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother 46: 1658-1664.
14. Lietchfield JT, Wilcoxon F, 1949. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99-113.
15. World Health Organization, 2001. The Use of Antimalarial Drugs. Report of an Informal Consultation. Geneva: World Health Organization. WHO/CDS/RBM/2001.33.
16. Facts on ACTs (ArtemisininBased Combination Therapies. Accessed February 1, 2006. Available from http://www.rbm.who .int/cmc_upload/0/000/015/ 364/RBMInfosheet_9.htm
17. Hutagalung R, Htoo H, Nwee P, Arunkamomkiri J, Zwang J, Carrara VI, Ashley E, Singhasivanon P, White N, Nosten F, 2006. A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am J Trop Med Hyg 74: 211-214.
18. Eckstein-Ludwig U, Webb RJ, van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S, 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957-961.
19. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, 2005. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol 12: 628-629.